Loading data for BDTX — first visit, this takes a few seconds.
Black Diamond Therapeutic... (BDTX)
NasdaqGS: BDTX
· Real-Time Price · USD
2.23
-0.04 (-1.76%)
At close: Aug 28, 2026, 3:59 PM
2.23
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Black Diamond Therapeutics Inc. (BDTX) Stock Price, Analysis & Data
-1.76% (1D)
| Bid | 1.65 |
| Market Cap | 127.78M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -42.55M |
| 3.29 | |
| -0.75 | |
| n/a | |
| -2.23 | |
| P/B (ttm) | 1.33 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 5, 2026 |
| Ask | 2.3 |
| Volume | 521,910 |
| Avg. Volume (20D) | 1,226,303 |
| Open | 2.28 |
| Previous Close | 2.27 |
| Day's Range | 2.17 - 2.29 |
| 52-Week Range | 1.60 - 4.94 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BDTX
Black Diamond Therapeutics, Inc., a clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is silevertinib, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in Phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as Phase 2 cl...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 31, 2020
Employees 21
Stock Exchange NasdaqGS
Ticker Symbol BDTX
Financial Performance
In 2025, Black Diamond Therapeutics's revenue was 70M, an increase of undefined% compared to the previous year's 0. Earnings were 22.37M, a decrease of -132.1%.
Financial StatementsEarnings Surprise
Black Diamond Therapeutics has released their quarterly earnings on Aug 5, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.17 exceeds estimates by 0.03, with 10.53% YoY growth.
Black Diamond Therapeutics Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2